Brown AM, Elbuluk O, Mertan F, Sankineni S, Margolis DJ, Wood BJ, et al. Recent advances in image-guided targeted prostate biopsy. Abdom Imaging 2015; 40: 1788-99. [CrossRef] Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MG. Magnetic Resonance Imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standart transrectal ultrasound-guided biopsy: a systematic review and meta- analysis. Eur Urol 2015; 68: 438-50. [CrossRef] Puech P, Rouviere O, Rennard-Penna R, Villers A, Devos P, Colombel M, et al. Prostate cancer diagnosis: Multiparametric MR-targeted biopsy with cognitive and transrectal US-MR Fusion guidance versus systematic biopsy-prospective multicenter study. Radiology 2013; 268: 461-9. [CrossRef] Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, et al. Comparison of MR/Ultrasound Fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015; 313: 390-7. [CrossRef] Murphy IG, NiMhurchu E, Gibney RG, McMahon CJ. MRI-directed cognitive fusion- guided biopsy of the anterior prostate tumors. Diagn Intrev Radiol 2017; 23: 87-93. [CrossRef] Verma S, Choyke PL, Eberhardt SC, Oto A, Tempany CM, Turkbey B, et al. The current state of MR Imaging –targeted biopsy techniques for detection of prostate cancer. Radiology 2017; 285: 343-56. [CrossRef] Wysock JS, Rosenkratz AB, Huang WC, Stifelman MD, Lepor H, Deng FM, et al. A prospective, blinded comparison of MR Imaging-Ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol 2014; 66: 343-51. [CrossRef] Wegelin O, van Melick H HE, Hooft L, Bosch JLHR, Reitsma HB, Barentsz JO, et al. Comparing three different techniques for magnetic resonance imaging –targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique? Eur Urol 2017; 71: 517-31. [CrossRef]